DR. WOLFGANG H DILLMAN, M.D.
Osteopathic Medicine at Arbor Dr, San Diego, CA

License number

California A33658

Personal information

See more information about WOLFGANG H DILLMAN at radaris.com

Name

Address

Phone

Wolfgang Dillman, age 84

355 S Nardo Ave, Solana Beach, CA 92075

(213) 324-3533

Wolfgang MD Dillman

Del Mar, CA

(858) 259-5726

Wolfgang M Dillman

355 Nardo Ave, Solana Beach, CA 92075

(858) 259-0460
(858) 259-5726

Professional information

See more information about WOLFGANG H DILLMAN at trustoria.com

Wolfgang Heinrich Dillman, San Diego CA

Specialties:

Internal Medicine, Endocrinology and Metabolism, Endocrinology, Diabetes & Metabolism

Work:

Va San Diego Healthcare System
3350 La Jolla Village Dr, San Diego, CA 92161 Ucsd Medical Group
9350 Campus Point Dr, La Jolla, CA 92037 UC San Diego Health System
200 W Arbor Dr, San Diego, CA 92103

Education:

Ludwig-Maximilians-Universitaet Munchen (1970)

Dr. Wolfgang H Dillman, San Diego CA - MD (Doctor of Medicine)

Specialties:

Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism

Address:

200 W Arbor Dr, San Diego 92103
(858) 534-9934 (Phone)
UCSD DEPT OF MEDICINE
9500 Gilman Dr, La Jolla 92093
(858) 534-9934 (Phone), (858) 534-9932 (Fax)

Certifications:

Diabetes, Metabolism & Endocrinology, 1977, Internal Medicine, 1973

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

200 W Arbor Dr, San Diego 92103
UCSD DEPT OF MEDICINE
9500 Gilman Dr, La Jolla 92093
UCSD Medical Center - Hillcrest
200 West Arbor Dr, San Diego 92103

Education:

Medical School
Ludwig Maximiliams University / Medical Faculty
City Hosp-Mt Sinai Hosp
Montefiore Hosp-Albert Einstein Coll Med
Montefiore Hosp

Method For Inhibition Of Phospholamban Activity For The Treatment Of Cardiac Disease And Heart Failure

US Patent:

2009014, Jun 11, 2009

Filed:

Oct 23, 2008

Appl. No.:

12/257329

Inventors:

KENNETH CHIEN - LA JOLLA CA, US
WOLFGANG DILLMAN - LA JOLLA CA, US
SUSUMU MINAMISAWA - LA JOLLA CA, US
HUAPING HE - LA JOLLA CA, US
MASAHIKO HOSHIJIMA - LA JOLLA CA, US
MARKUS MEYER - LA JOLLA CA, US
CHRISTOPHER SCOTT - SAN DIEGO CA, US
YIBIN WANG - LA JOLLA CA, US
GREGG J. SILVERMAN - LA JOLLA CA, US

International Classification:

A61K 31/7088, A61P 9/00

US Classification:

514 44

Abstract:

The present invention provides a method for the treatment of heart failure through the use of small peptide complexes and recombinant proteins which function to enhance contractility in failing hearts and reduce blood pressure in individuals with hypertension by inhibiting the interaction between phospholamban and sacroplasmic reticulum Ca ATPase (SERCA2a) within cardiomyocytes. In addition, a means is provided for the transport of such therapeutic agents into the cytoplasm and nucleus of cardiomyocytes.

Method For Inhibition Of Phospholamban Activity For The Treatment Of Cardiac Disease And Heart Failure

US Patent:

2004012, Jun 24, 2004

Filed:

Nov 10, 2003

Appl. No.:

10/705791

Inventors:

Kenneth Chien - La Jolla CA, US
Wolfgang Dillman - La Jolla CA, US
Susumu Minamisawa - La Jolla CA, US
Huaping He - La Jolla CA, US
Masahiko Hoshijima - La Jolla CA, US
Markus Meyer - La Jolla CA, US
Christopher Scott - San Diego CA, US
Yibin Wang - La Jolla CA, US
Gregg Silverman - La Jolla CA, US

International Classification:

A61K038/17, A61K048/00, A61K039/395

US Classification:

514/007000, 514/044000, 424/130100

Abstract:

The present invention provides a method for the treatment of heart failure through the use of small peptide complexes and recombinant proteins which function to enhance contractility in failing hearts and reduce blood pressure in individuals with hypertension by inhibiting the interaction between phospholamban and sarcoplasmic reticulum Ca ATPase (SERCA2a) within cardiomyocytes. In addition, a means is provided for the transport of such therapeutic agents into the cytoplasm and nucleus of cardiomyocytes.